Butylated Hydroxytoluene vs Advantame: which is worse?
Quick answer: Butylated Hydroxytoluene carries the heavier risk profile. Butylated Hydroxytoluene is — in the EU and — in the US; Advantame is — in the EU and — in the US.
| Property | Butylated Hydroxytoluene | Advantame |
|---|---|---|
| EU status | — | — |
| US status | — | — |
| Risk level | — | — |
| Banned in | Japan (banned for food use) | — |
| Restricted in | European Union (ADI-based restrictions), United Kingdom, Australia | European Union (ADI 5 mg/kg body weight) |
| Category | additive | additive |
| Where it hides | — | — |
What is Butylated Hydroxytoluene?
Butylated hydroxytoluene (BHT) is a synthetic phenolic antioxidant preservative derived from petroleum. A white crystalline solid with formula C15H24O, it prevents fat oxidation in processed foods, cosmetics, and industrial applications. Often used synergistically with BHA.
What is Advantame?
Advantame is the newest FDA-approved synthetic sweetener, approved in 2014. Like neotame, it is a structural derivative of aspartame but with a vanillin-derived substituent. It is approximately 20,000 times sweeter than sucrose — the most potent sweetener currently approved for food use in the US.
Documented risks
Butylated Hydroxytoluene: BHT has complex, bidirectional carcinogenicity data — some NTP bioassays found liver tumors in female mice at high doses, while other studies suggested BHT might inhibit cancer initiation. IARC has not formally classified BHT due to conflicting evidence. A 2017 study linked BHT to thyroid hormone disruption in female rats. The American Academy of Pediatrics (2018) recommended reducing synthetic preservative exposure including BHT in children. Kellogg's uses vitamin E in European versions of cereals that contain BHT in US versions — a commercially meaningful substitution.
Advantame: Advantame is the newest approved high-intensity sweetener with the least post-approval safety data. The FDA approval was based on extensive pre-market animal studies showing no significant toxicity, carcinogenicity, reproductive toxicity, or neurotoxicity at relevant doses. EFSA approved it for EU use in 2014, finding no safety concerns based on the submitted data. Like other synthetic sweeteners, advantame has not been studied for long-term effects in large human populations post-approval. The same gut microbiome and glucose tolerance concerns raised for other sweeteners (aspartame, sucralose, acesulfame K) have not been specifically studied for advantame, though the class-wide concerns are relevant. Given its 2014 approval date, independent long-term safety studies are still limited.
Scan a barcode and we'll flag both Butylated Hydroxytoluene and Advantame (plus 200+ other ingredients banned overseas).
Scan free →